Quest PharmaTech Inc faced a significant decline in stock value, raising concerns among investors about its future.
Yesterday, Quest PharmaTech Inc (QPT.V) saw a staggering drop of 33.33%, closing at just CA$0.02. This sharp decline has left many investors questioning the company's stability and future prospects.
Advertisement
Quest PharmaTech Inc
QPT.V
QPT.V
Quest PharmaTech Inc
WealthAwesomeMarket cap
$4.23M
P/E
0.8x
52W high
$0.05
52W low
$0.02
1W change
-33.33%
Beta
-0.46
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on QPT's historical volatility
30-Day Vol
252.9%
Annualized
90-Day Vol
224.0%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.02
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.02 | C$0.01 – C$0.05 |
| 60 trading days | C$0.02 | C$0.01 – C$0.06 |
| 90 trading days | C$0.02 | C$0.00 – C$0.08 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: With no recent positive news to counterbalance the stock's steep decline, investors should proceed with caution when considering Quest PharmaTech.
Stock Drops 33.33% in One Day
The dramatic decline in Quest PharmaTech's stock value highlights investor uncertainty and potential underlying issues within the company.
Bull case
Despite the recent downturn, Quest PharmaTech's focus on targeted cancer therapies could offer long-term opportunities if they successfully advance their lead product.
Bear case
The sudden drop in stock price, combined with a lack of recent positive news and a low market cap of CA$3.38 million, raises concerns for potential investors.
Stock Performance Overview
Advertisement
Quest PharmaTech Inc's stock plummeted by 33.33% in yesterday's trading session, closing at CA$0.02. This dramatic decline has raised alarms among investors, especially given the company's recent lack of positive developments.
Market Reaction and Investor Sentiment
The market's reaction to Quest PharmaTech's stock drop reflects a broader sentiment of uncertainty. With a market cap of CA$3.38 million and no recent announcements to boost investor confidence, many are left questioning the company's viability.
What Lies Ahead for Quest PharmaTech
Looking ahead, investors will need to keep an eye on any updates from Quest PharmaTech regarding their product developments and financial health. The company's focus on targeted cancer therapies remains a potential bright spot, but the recent stock performance suggests caution is warranted.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
